Showing results (1-10 of 126) with videos related to
Sort By:
Pageof 13
Journal of Blood Medicine|September 13, 2021
Waldenström's Macroglobulinemia: An Exploration into the Pathology and Diagnosis of a Complex B-Cell MalignancyElham Askari, Sara Rodriguez, Ramon Garcia-SanzImmunologic Research|November 14, 2013
Semaphorin7A: branching beyond axonal guidance and into immunityRamon Garcia-Areas, Stephania Libreros, Vijaya Iragavarapu-CharyuluImmunologic Research|November 14, 2013
CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factorsStephania Libreros, Ramon Garcia-Areas, Vijaya Iragavarapu-CharyuluThe International Journal of Esthetic Dentistry|January 25, 2017
Soft and hard tissue management in the treatment of a discolored single tooth in the esthetic zoneDavid Garcia-Baeza, Ramon Garcia-Adamez, Carlos SaavedraACS Omega|July 21, 2020
Molecular Topology QSAR Strategy for Crop Protection: New Natural Fungicides with Chitin Inhibitory ActivityMaria Galvez-Llompart, Riccardo Zanni, Jorge Galvez, et al.Expert Opinion on Drug Discovery|June 5, 2020
What place does molecular topology have in today's drug discovery?Riccardo Zanni, Maria Galvez-Llompart, Ramon Garcia-Domenech, et al.Expert Opinion on Drug Discovery|January 8, 2013
Advances in the molecular modeling and quantitative structure-activity relationship-based design for antihistaminesJorge Galvez, Maria Galvez-Llompart, Riccardo Zanni, et al.CPT: Pharmacometrics & Systems Pharmacology|August 19, 2024
Bayesian sparse regression for exposure-response analyses of efficacy and safety endpoints to justify the clinical dose of valemetostat for adult T-cell leukemia/lymphomaMasato Fukae, James Rogers, Ramon Garcia, et al.International Journal of Nephrology and Renovascular Disease|October 29, 2020
Mesoamerican Nephropathy (MeN): What We Know so FarVicente Sanchez Polo, Ramon Garcia-Trabanino, Guillermo Rodriguez, et al.Pharmaceuticals (Basel, Switzerland)|January 21, 2022
How Molecular Topology Can Help in Amyotrophic Lateral Sclerosis (ALS) Drug Development: A Revolutionary Paradigm for a Merciless DiseaseMaria Galvez-Llompart, Riccardo Zanni, Ramon Garcia-Domenech, et al.Pageof 13